U.S. markets closed

Amarin Corporation plc (AMRN)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
4.9500+0.0700 (+1.43%)
At close: 4:00PM EDT

Amarin Corporation plc

Grand Canal Docklands
Block C 77 Sir John Rogerson's Quay
Dublin 2
Ireland
353 1 669 9020
http://www.amarincorp.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees1,000

Key Executives

NameTitlePayExercisedYear Born
Mr. John F. TheroPres, CEO & Director1.37M543.28k1961
Mr. Michael W. KalbCFO, Sr. VP & Assistant Sec.656.66kN/A1971
Dr. Steven B. KetchumPres of R&D, Sr. VP and Chief Scientific Officer758.14kN/A1965
Mr. Joseph T. KennedyExec. VP, Gen. Counsel & Strategic Initiatives and Sec.762.77kN/A1968
Mr. Aaron D. BergSr. VP & Chief Commercial Officer656.09kN/A1963
Ms. Elisabeth SchwartzSr. Director of Investor RelationsN/AN/AN/A
Mr. Daniel S. DunhamSr. VP & Chief Pharmaceutical Compliance OfficerN/AN/AN/A
Alina KolomeyerDirector of CommunicationsN/AN/AN/A
Mr. Rami DaoudSr. VP of Corp. Devel.N/AN/AN/A
Ms. Donna PasekSr. VP of HRN/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, and eicosapentaenoic acid. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.

Corporate Governance

Amarin Corporation plc’s ISS Governance QualityScore as of June 1, 2021 is 7. The pillar scores are Audit: 8; Board: 8; Shareholder Rights: 8; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.